FDA.reportPublic FDA data

PRILOCAINE

Substance profile for UNII 046O35D44R, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for PRILOCAINE
Structure render from PubChem CID 4906

Substance Identity#

UNII
046O35D44R
Preferred term
PRILOCAINE
Registry number
721-50-6
EC number
211-957-0
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C13H20N2O
Chemical structure for PRILOCAINE
Structure render from PubChem CID 4906

Chemical And Database Identifiers#

SMILES
CCCNC(C)C(=O)NC1=CC=CC=C1C
RxCUI
8686
PubChem
4906
NCIt
C47685
INN ID
1641

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound4906https://pubchem.ncbi.nlm.nih.gov/compound/4906
RxNorm8686https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=8686
NCI ThesaurusC47685https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47685
FDA Substance Registration System046O35D44Rhttps://precision.fda.gov/uniisearch/srs/unii/046O35D44R
European Community number211-957-0https://commonchemistry.cas.org/results?q=211-957-0

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PRILOCAINEACTIVE INGREDIENT046O35D44RInflamation Reduction Pack These highlights do not include all the information needed to use Inflammation Reduction Pack safely and effectively.see full prescribing information for Inflammation Reduction Pack Inflammation Reduction Pack (Inflammation Reduction Pack) KIT for use. Initial U.S. Approval:4
PRILOCAINEACTIVE MOIETY046O35D44RInflamation Reduction Pack These highlights do not include all the information needed to use Inflammation Reduction Pack safely and effectively.see full prescribing information for Inflammation Reduction Pack Inflammation Reduction Pack (Inflammation Reduction Pack) KIT for use. Initial U.S. Approval:4
PRILOCAINEACTIVE MOIETY046O35D44RInflamation Reduction Pack These highlights do not include all the information needed to use Inflammation Reduction Pack safely and effectively.see full prescribing information for Inflammation Reduction Pack Inflammation Reduction Pack (Inflammation Reduction Pack) KIT for use. Initial U.S. Approval:3
PRILOCAINEACTIVE INGREDIENT046O35D44RInflamation Reduction Pack These highlights do not include all the information needed to use Inflammation Reduction Pack safely and effectively.see full prescribing information for Inflammation Reduction Pack Inflammation Reduction Pack (Inflammation Reduction Pack) KIT for use. Initial U.S. Approval:3
PRILOCAINEACTIVE MOIETY046O35D44RRELADOR PAK PLUS (Lidocaine 2.5% and Prilocaine 2.5%) Cream with Occlusive Dressing For Topical Use Only. Not for Ophthalmic Use.2
PRILOCAINEACTIVE INGREDIENT046O35D44RRELADOR PAK PLUS (Lidocaine 2.5% and Prilocaine 2.5%) Cream with Occlusive Dressing For Topical Use Only. Not for Ophthalmic Use.2
PRILOCAINEACTIVE MOIETY046O35D44RLidocaine 2.5% and Prilocaine 2.5% Cream For Topical Use Only. Not for Ophthalmic Use.3
PRILOCAINEACTIVE INGREDIENT046O35D44RLidocaine 2.5% and Prilocaine 2.5% Cream For Topical Use Only. Not for Ophthalmic Use.3
PRILOCAINEACTIVE MOIETY046O35D44RLidocaine 2.5% and Prilocaine 2.5% Cream1
PRILOCAINEACTIVE INGREDIENT046O35D44RLidocaine 2.5% and Prilocaine 2.5% Cream1
PRILOCAINEACTIVE INGREDIENT046O35D44RGeneral Surgery Kit1
PRILOCAINEACTIVE MOIETY046O35D44RGeneral Surgery Kit1
PRILOCAINEACTIVE INGREDIENT046O35D44RLidocaine 2.5% and Prilocaine 2.5% Cream1
PRILOCAINEACTIVE MOIETY046O35D44RLidocaine 2.5% and Prilocaine 2.5% Cream1
prilocaineACTIVE MOIETY046O35D44RLIDOCAINE and PRILOCAINE CREAM, 2.5%/2.5%1
prilocaineACTIVE INGREDIENT046O35D44RLIDOCAINE and PRILOCAINE CREAM, 2.5%/2.5%1
prilocaineACTIVE INGREDIENT046O35D44RLIDOCAINE and PRILOCAINE CREAM, 2.5%/2.5%1
prilocaineACTIVE MOIETY046O35D44RLIDOCAINE and PRILOCAINE CREAM, 2.5%/2.5%1
prilocaineACTIVE MOIETY046O35D44RLIDOCAINE AND PRILOCAINE CREAM [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]8
prilocaineACTIVE INGREDIENT046O35D44RLIDOCAINE AND PRILOCAINE CREAM [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]8
prilocaineACTIVE MOIETY046O35D44RCITANEST FORTE (PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [DENTSPLY PHARMACEUTICAL INC.]7
PRILOCAINEACTIVE INGREDIENT046O35D44RLIDOCAINE AND PRILOCAINE CREAM [HI-TECH PHARMACAL CO., INC.]7
PRILOCAINEACTIVE MOIETY046O35D44RLIDOCAINE AND PRILOCAINE CREAM [HI-TECH PHARMACAL CO., INC.]7
PRILOCAINEACTIVE INGREDIENT046O35D44RLIDOCAINE-PRILOCAINE-CREAM BASE CREAM [HUMCO HOLDING GROUP, INC.]6
PRILOCAINEACTIVE MOIETY046O35D44RLIDOCAINE-PRILOCAINE-CREAM BASE CREAM [HUMCO HOLDING GROUP, INC.]6
prilocaineACTIVE MOIETY046O35D44RORAQIX (LIDOCAINE AND PRILOCAINE) GEL [DENTSPLY PHARMACEUTICAL]6
prilocaineACTIVE INGREDIENT046O35D44RORAQIX (LIDOCAINE AND PRILOCAINE) GEL [DENTSPLY PHARMACEUTICAL]6
prilocaineACTIVE MOIETY046O35D44RCITANEST PLAIN (PRILOCAINE HYDROCHLORIDE) INJECTION, SOLUTION [DENTSPLY PHARMACEUTICAL INC.]4
PRILOCAINEACTIVE INGREDIENT046O35D44RLIVIXIL PAK (LIDOCAINE 2.5% AND PRILOCAINE 2.5%) KIT [ALVIX LABORATORIES, LLC]3
PRILOCAINEACTIVE MOIETY046O35D44RLIVIXIL PAK (LIDOCAINE 2.5% AND PRILOCAINE 2.5%) KIT [ALVIX LABORATORIES, LLC]3
prilocaineACTIVE INGREDIENT046O35D44REMLA (LIDOCAINE AND PRILOCAINE) CREAM [OAK PHARMACEUTICALS, INC. (SUBSIDIARY OF AKORN, INC.) ]2
prilocaineACTIVE MOIETY046O35D44REMLA (LIDOCAINE AND PRILOCAINE) CREAM [OAK PHARMACEUTICALS, INC. (SUBSIDIARY OF AKORN, INC.) ]2
PRILOCAINEACTIVE INGREDIENT046O35D44RLIDOCAINE AND PRILOCAINE CREAM [ACTAVIS PHARMA, INC.]2
PRILOCAINEACTIVE MOIETY046O35D44RLIDOCAINE AND PRILOCAINE CREAM [ACTAVIS PHARMA, INC.]2
prilocaineACTIVE INGREDIENT046O35D44RLIDOCAINE AND PRILOCAINE CREAM [AKORN, INC. ]2
prilocaineACTIVE MOIETY046O35D44RLIDOCAINE AND PRILOCAINE CREAM [AKORN, INC. ]2
PRILOCAINEACTIVE MOIETY046O35D44RLIDOCAINE AND PRILOCAINE CREAM [PREFERRED PHARMACEUTICALS, INC.]2
PRILOCAINEACTIVE INGREDIENT046O35D44RLIDOCAINE AND PRILOCAINE CREAM [PREFERRED PHARMACEUTICALS, INC.]2
PRILOCAINEACTIVE INGREDIENT046O35D44RLP LITE PAK (LIDOCAINE 2.5% AND PRILOCAINE 2.5%) KIT [ALVIX LABORATORIES, LLC]2
PRILOCAINEACTIVE MOIETY046O35D44RLP LITE PAK (LIDOCAINE 2.5% AND PRILOCAINE 2.5%) KIT [ALVIX LABORATORIES, LLC]2
PRILOCAINEACTIVE MOIETY046O35D44REMLA (LIDOCAINE AND PRILOCAINE) CREAM [ACTAVIS PHARMA, INC.]1
PRILOCAINEACTIVE INGREDIENT046O35D44REMLA (LIDOCAINE AND PRILOCAINE) CREAM [ACTAVIS PHARMA, INC.]1
PRILOCAINEACTIVE INGREDIENT046O35D44REMLA (LIDOCAINE) CREAM [APP PHARMACEUTICALS, LLC]1
PRILOCAINEACTIVE MOIETY046O35D44REMLA (LIDOCAINE) CREAM [APP PHARMACEUTICALS, LLC]1
PRILOCAINEACTIVE MOIETY046O35D44RLIDOCAINE AND PRILOCAINE CREAM [DIRECT RX]1
prilocaineACTIVE INGREDIENT046O35D44RLIDOCAINE AND PRILOCAINE CREAM [DIRECT RX]1
PRILOCAINEACTIVE INGREDIENT046O35D44RLIDOCAINE AND PRILOCAINE CREAM [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]1
PRILOCAINEACTIVE MOIETY046O35D44RLIDOCAINE AND PRILOCAINE CREAM [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]1
PRILOCAINEACTIVE INGREDIENT046O35D44RLIDOCAINE AND PRILOCAINE CREAM [PREFERRED PHARMACEUTICALS, INC.]1
PRILOCAINEACTIVE MOIETY046O35D44RLIDOCAINE AND PRILOCAINE CREAM [PREFERRED PHARMACEUTICALS, INC.]1
PRILOCAINEACTIVE MOIETY046O35D44RLIDOCAINE AND PRILOCAINE CREAM [PROFICIENT RX LP]1
PRILOCAINEACTIVE INGREDIENT046O35D44RLIDOCAINE AND PRILOCAINE CREAM [PROFICIENT RX LP]1
prilocaineACTIVE MOIETY046O35D44RPRILOCAINE HYDROCHLORIDE INJECTION, SOLUTION [SEPTODONT INC.]1
prilocaineACTIVE MOIETY046O35D44RPRILOCAINE HYDROCHLORIDE WITH EPINEPHRINE (PRILOCAINE AND EPINEPHRINE) INJECTION, SOLUTION [SEPTODONT INC.]1